Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
AssigneeIncozen Therapeutics Pvt. Ltd.
InventorSwaroop K. VAKKALANKA
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to pharmaceutical compositions useful for (and to a method of) treating autoimmune, respiratory and/or inflammatory diseases and conditions. The method involves administering to a subject in need thereof roflumilast N-oxide by inhalation. The present disclosure particularly relates to the treatment of asthma and chronic obstructive pulmonary disease (COPD) by administering roflumilast N-oxide by inhalation.
Claims33
A method of treating an autoimmune, respiratory or inflammatory disease or condition in a subject in need thereof comprising pulmonary administration of an effective amount of roflumilast N-oxide or a pharmaceutically acceptable salt thereof.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Roflumilast N-oxide having a d50 of less than about 10 microns.
(canceled)
(canceled)
(canceled)
A pharmaceutical composition comprising roflumilast N-oxide and, optionally, one or more pharmaceutically acceptable carriers and/or excipients, wherein the composition is administrated by inhalation.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.